Immunohistochemistry (IHC) is used to detect the deletion of FH expression in tumor cells to diagnose FH-deficient renal cell carcinoma, which has been proved to be closely related to the inactivation mutation of the FH gene (Smith et al., 2016). This evidence concerns the gene FH and renal cell carcinoma.